Skip to content
Sarcoma research consortium of Quebec.
We are
SaRC-Q is a pioneering consortium of medical oncologists spanning across Quebec, united by a steadfast commitment to delivering the highest quality of care to patients battling sarcoma. Our core mission is to not only provide exceptional care but also to bring cutting-edge treatments and clinical trials within reach for those afflicted by this rare disease. Join us in the fight against sarcoma as we strive to improve the lives of patients and transform the future of sarcoma care.

Latest News

Please see our latest events and work-related news from our team.

SaRC- Q Database

The SaRC-Q registry aims to enhance the understanding of sarcoma and its implications for cancer patients in Quebec.

Number of patients
in our registry
Number of
participating sites

Sarcoma Sub-Type




Bone Sarcoma


Soft-Tissue Sarcoma



SaRC-Q Registry

The SaRC-Q registry is dedicated to establishing a robust sarcoma research infrastructure in Quebec. Our primary goal is to provide essential support for projects that will enhance our comprehension of this disease, ultimately leading to the optimization of clinical practices. We are committed to advancing knowledge, improving patient care, and fostering innovation in the field of sarcoma research.


Clinical Trials

Clinical trials play a pivotal role in the treatment of sarcoma, a disease often characterized by limited therapeutic options. These trials offer patients a vital pathway to access cutting-edge technologies and advanced drug therapies. By participating in clinical trials, patients not only contribute to the advancement of sarcoma treatment but also have the potential to significantly benefit from the latest breakthroughs in medical science.

Subscribe to Our Newsletter

Stay connected with us and stay ahead of the latest developments in sarcoma research. By subscribing to our newsletter, you will receive timely updates whenever a new clinical trial becomes available within SaRC-Q. Join us in the quest for a brighter future in sarcoma care.

Subscribe To Our Newsletter